Four-drug attack on stubborn stomach cancer shows promise
NCT ID NCT07392346
Summary
This study tests whether combining four different drugs can help control advanced stomach cancer that has continued to grow despite initial immunotherapy treatment. The trial will enroll 68 adults whose cancer has spread and who previously received immunotherapy that stopped working. Researchers want to see if this combination of targeted therapy, chemotherapy, and two immunotherapy drugs can slow cancer growth better than current second-line options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER ADENOCARCINOMA METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hospital, Beijing
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.